General Information of the Compound
Compound ID
CP0953816
Compound Name
(R)-2-(2-Benzylazepan-1-yl)-6-morpholinopyrimidin-4(3H)-one
    Show/Hide
Structure
Formula
C21H28N4O2
Molecular Weight
368.481
Canonical SMILES
O=c1cc(N2CCOCC2)nc(N2CCCCC[C@@H]2Cc2ccccc2)[nH]1
    Show/Hide
InChI
InChI=1S/C21H28N4O2/c26-20-16-19(24-11-13-27-14-12-24)22-21(23-20)25-10-6-2-5-9-18(25)15-17-7-3-1-4-8-17/h1,3-4,7-8,16,18H,2,5-6,9-15H2,(H,22,23,26)/t18-/m1/s1
    Show/Hide
InChIKey
VMAXCDSINZOJPZ-GOSISDBHSA-N
Physicochemical Property
logP
2.5982
Rotatable Bonds
4
Heavy Atom Count
27
Polar Areas
61.46
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 156458088
ChEMBL ID
CHEMBL4850755
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 0.1 nM